Company intelligence / Profile preview

Cellbricks Therapeutics

Berlin, Berlin, Germany
Ownership
Private
Employees
~25
Development stage
Other
01

Overview

Cellbricks is a specialized biotechnology company focused on the development of 3D bioprinted human tissues for regenerative medicine and therapeutic applications. Utilizing a proprietary high-resolution stereolithographic bioprinting technology, the company creates complex, vascularized tissue structures that mimic natural human biology. Their primary therapeutic focus is on soft tissue reconstruction, offering solutions for patients requiring tissue replacement due to oncology, trauma, or congenital defects. Beyond therapeutics, Cellbricks provides 'Organ-on-a-Chip' models and bioprinted scaffolds to support drug development and academic research. The company aims to revolutionize the field of tissue engineering by providing off-the-shelf biological implants that integrate seamlessly with the patient's own body.

Therapeutic areas
DermatologyWomen's HealthOther
Modalities
Cell therapyHydrogel-based drug delivery therapy3D Bioprinting
Industry
Biotech
02

Drug pipeline

2 assets

CBX 200

Preclinical

1 more asset in the full pipeline.

Request access →
03

Partnerships

Charité - Universitätsmedizin Berlin

Beyond the preview

Go deeper on Cellbricks Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellbricks Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call